Desmopressin is a synthetic analog of the peptide hormone vasopressin in which the N-terminal ␣-amino group has been removed and L-arginine in position 8 has been replaced by D-arginine. Using 1 H-NMR spectroscopy, we show that desmopressin binds to neurophysin-II, whereas deamino-vasopressin does not bind. Thus, the change in configuration at Arg 8 causes a significant difference in the binding of these hormones to neurophysin-II. We have determined the structure of desmopressin bound to neurophysin-II using two-dimensional 
1
H nuclear magnetic resonance-transferred nuclear Overhauser effect techniques. A common binding motif for vasopressin and desmopressin is proposed that includes a positive charge group along with the hydrophobic surface formed by the side chains of Tyr 2 and a ␤-methylene provided by Phe-3. In vasopressin, the positive charge is provided by the N-terminal NH 3 ؉ , whereas in desmopressin, the side chain of Arg-8 contributes the positive charge. The type II ␤-turn found in residues Cys Neurophysin is a carrier protein for the peptide hormones vasopressin and oxytocin. The neurophysin precursor is composed of both the peptide hormone and neurophysin connected by a tri-peptide Gly-Lys-Arg linker, which is processed into the hormone and mature neurophysin after packaging into neurosecretory granules. The processed hormone and neurophysin form a noncovalent complex that dissociates after dilution upon secretion into the blood (1) . The vasopressin/oxytocin-neurophysin complexes provide good model systems for the recognition and binding of flexible peptides by proteins (1) . The current view of the interaction in the hormone-neurophysin complexes suggests that the N-terminal ␣-amino group and residue Tyr 2 play central roles (1, 2) . It has also been suggested that the C-terminal three-residue tail in these hormones is not involved in binding (1) . This model is consistent with most known experimental results. For example, deamino-oxytocin fails to bind to neurophysin because its N-terminal ␣-amino group is replaced by a hydrogen (1) . Also, dipeptides or tripeptides related to the N-terminal sequence of these hormones bind to neurophysin with affinities only slightly weaker than the natural hormones (3, 4) . The crystal structure of the complex between a dipeptide Phe-Tyr-NH 2 with neurophysin-II largely confirms the current view of the interactions between hormones and neurophysin as deduced from spectroscopic and thermodynamic studies (5) . Lippens et al. (6) solved the solution conformation of oxytocin bound to neurophysin-I by NMR transferred NOE 1 techniques, thereby providing further insight into the structure of hormone-neurophysin complexes. More recently, the crystal structure of the oxytocin-neurophysin complex has been published, which again confirms the importance of the N-terminal NH 3 ϩ group and the aromatic side chain of Tyr 2 for the binding of the peptide hormone oxytocin to neurophysin (7) .
In the present study, transferred NOE and molecular modeling techniques have been used to study the desmopressinneurophysin-II complex. Desmopressin is a synthetic analog of vasopressin with specific antiduiretic activity and antibleeding activity (8) . It interacts specifically with the vasopressin receptor subtype V2 (8) . The specificity of its biological activity makes desmopressin one of the most important analogs of vasopressin for clinical applications (8) . Desmopressin differs from vasopressin in two positions. The N-terminal ␣-amino group of vasopressin is replaced by a hydrogen (deamino-vasopressin), and the L-arginine at position 8 is replaced by Darginine. Both desmopressin and deamino-vasopressin are not expected to bind to neurophysin because they lack an N-terminal ␣-amino group. However, using 1 H-NMR transferred NOE techniques, we demonstrate herein that desmopressin does indeed bind to neurophysin-II.
The structure of desmopressin bound to bovine neurophysin-II has been generated based on distance restraints derived from two-dimensional 1 H-NMR transferred NOE data. Based on this structure, a binding motif is proposed for desmopressin that indicates a critical and novel role of the C-terminal threeresidue tail of desmopressin. This binding motif suggests new probabilities for interactions within hormone-neurophysin complexes.
EXPERIMENTAL PROCEDURES
Sample Preparation-Desmopressin and deamino-vasopressin were synthesized by solid-phase peptide synthesis method and was purified by reverse-phase high-performance liquid chromatography (11) . Pure bovine neurophysin-II was isolated from acetone powder prepared from bovine posterior pituitary lobes and purified using methods reported * The preliminary results of this work were presented in the 8th Annual Meeting of American Protein Society on July 11, 1994 . This work was supported by the Protein Engineering Network of Centres of Excellence, funded by the Government of Canada, and supported by National Institutes of Health Grant GM-17528 (to E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by a Protein Engineering Network of Centres of Education postdoctoral fellowship.
ʈ To whom correspondence should be addressed. NMR Experiments-All NMR experiments were performed on a Varian VXR-500 NMR spectroscopy. NMR experiments were acquired at 5°C. Transferred NOESY (18) experiments were recorded with 50-, 100-, 150-, 200-, 250-, and 300-ms mixing times. The NOESY and two-dimensional rotating frame nuclear Overhauser spectroscopy experiments of free peptide sample (1-2 mM) was acquired with the 500-ms mixing time. The spectral widths were 6000 Hz in both dimensions, with 1024 complex points in the T 2 dimension and 512-600 free induction decays in the T 1 dimension. Presaturation was used for all NMR experiments for suppressing the water peak.
Interproton Distance Restraints and Structure Calculations-Interproton distance restraints were obtained by the integration of the cross-peaks from a transferred NOESY spectrum at the 150-ms mixing time. Using the average reference distance of 2.50 Å for the ␤ to ␦ protons of Phe 3 , the integrals of all cross-peaks were then converted into distance restraints. Four groups of distance restraints were obtained according to the peak intensities: very weak, weak, medium, and strong, which corresponded to the upper boundary of 6.0, 5.0, 3.5, and 2.7 Å. The lower boundaries of distance restraints were set to 1.8 Å for strong and medium transferred NOEs, to 2.3 Å for weak peaks, and to 2.8Å for very weak peaks. The appropriate distance corrections were made for aromatic ring protons and the pseudoatoms of non-stereospecifically assigned methylene protons to allow centroid averaging (19) . A total of 248 transferred NOE distance restraints were used, which included 88 intra-residue and 160 inter-residue distance restraints and 79 medium-and long-ranged distance restraints, in the structure generation procedure based on NOE distance restraints. In the first several iterations, only NOE distance restraints were used; in the later iterations, four hydrogen bond distance restraints were included into the calculations because the structures generated in the earlier iterations indicated that two hydrogen bonds existed. A total of 50 structures were generated in each iteration. Using transferred NOE data, the bound structure of desmopressin was generated by PEPFLEX-II, which is an iterative structure building procedure (12, 20) , and includes a restrained simulated annealing and a full relaxation matrix analysis. The molecular modeling was achieved by using DISCOVER (BIOSYM, San Diego, CA) running on a Silicon Graphics 4D/240 computer. In all calculations, a cutoff distance of 8.0 Å was chosen; chiral restraints were used to retain right chiralities of all residues. Peptide bonds were also constrained into trans geometry. Charge interaction and all crossterm interactions were switched off during the simulation. Fig.  1 compares the amide-proton region of the one-dimensional 1 H-NMR spectra of desmopressin as a function of the added fraction of bovine neurophysin-II (molar ratio). These spectra show line-broadening of the amide-proton peaks of desmopressin as a function of the concentration of neurophysin-II. No significant chemical shift changes were observed. 2 In these spectra, we assume that the free7bound peptide exchange is in the NMR fast exchange limit for both the NOE timescale and the chemical shift timescale because of the weak affinities involved (1) . An estimation of the binding constant of desmopressin to neurophysin-II is about 200 M
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, which is based on NMR experiments (line width versus neurophysin concentration) and competitive binding studies (data not shown). The line-broadening of amide-proton peaks indicates an interaction between the peptide and bovine neurophysin-II. The binding of desmopressin to neurophysin-II also induces new 1 H-NMR transferred NOE cross-peaks. Fig. 2, A and B , compare the two-dimensional 1 H-NMR transferred NOESY spectra of desmopressin in the presence of 0.1 added molar ratio of neurophysin-II with the two-dimensional 1 H-NMR NOESY spectra of the peptide free in aqueous solution. Transferred NOEs develop upon binding to neurophysin-II, resulting in a larger number and more intense NOE cross-peaks at a 150-ms mixing time than those observed at a 500-ms mixing time in the absence of protein. 3 Many of these new transferred NOE crosspeaks arise from side chain to side chain nuclei as indicated in Fig. 2 .
Differences between Desmopressin and Deamino-vasopressin in the Presence of Neurophysin-II-We have also used twodimensional 1 H-NMR transferred NOE techniques to study deamino-vasopressin. The transferred NOESY spectrum of deamino-vasopressin in the presence of 0.1 added molar ratio of neurophysin-II showed no significant differences from the NOESY spectrum of the free peptide (data not shown). Fig. 2 shows that no significant differences are observed between the NOESY spectrum of the desmopressin in the absence of neurophysin-II ( Fig. 2A) and the transferred NOESY spectrum of deamino-vasopressin in the presence of 0.1 added molar ratio of neurophysin-II (Fig. 2C) , indicating that there is no binding. Since the L/D difference in the configuration of Arg 8 of desmopressin and deamino-vasopressin results in such a striking difference in their binding to neurophysin-II, a conformational difference in these two peptides might be expected. Fig. 3 shows the ␣H-NH regions of two-dimensional 1 H-NMR NOESY spectrum of desmopressin in the absence of neurophysin-II (Fig. 3A) and the same region of transferred NOESY spectra of desmopressin (Fig. 3B ) and deamino-vasopressin (Fig. 3C ) in the presence of 0.1 added molar ratio of bovine neurophysin-II. Changes are observed in the NOEs that characterize the structure of residues 6 -9; for example, the d ␣N (7, 9) cross-peak (marked by a box) is seen in Fig. 3A (weak intensity) and Fig.  3B (medium intensity) but not in Fig. 3C . In addition (data not shown), the d NN (8, 9) cross-peak is seen in the NH-NH region of NOESY (medium intensity) and transferred NOESY (strong intensity) spectra of desmopressin in the absence/presence of 2 The chemical shift assignment of desmopressin is reported in Ref.
12. 3 The buildup curve of NOESY spectra of desmopressin in the absence of neurophysin-II was linear up to 300 ms, whereas that of transferred NOESY of desmopressin in presence of 0.1 added molar ratio of neurophysin-II was linear only up to 150 ms. 
Binding of Desmopressin and Vasopressin to Neurophysin-II
0.1 added molar ratio of neurophysin-II, but is not seen in the transferred NOESY spectrum of deamino-vasopressin in the presence of 0.1 added molar ratio of neurophysin-II. These NOE results identify a ␤-turn in residues Cys 6 -Pro 7 -D-Arg 8 -Gly 9 in both free and bound desmopressin. Evidence for such a structure is not found among the same residues of deaminovasopressin. While the NOEs d ␣N (7, 9) and d NN (8, 9) characterize the existence of a ␤-turn in these residues, the 3 J ␣H-NH coupling constant of 5.0 -5.5 Hz for residue Arg 8 of desmopressin indicates that this turn is a type II ␤-turn (9). Actually, the sequence of Pro-D-Arg at positions iϩ1 and iϩ2 is known to favor a type II ␤-turn (10). Interestingly, this type II ␤-turn was also found in the structures of desmopressin in both aqueous and trifluoroethanol solutions (11, 12) . , as well as from ␤-CH 2 atoms of Cys 6 to the C-terminal NH 2 atoms of Gly 9 . The NOEs from residue Arg 8 to Tyr 2 and Phe 3 are surprising because they are not observed in either aqueous or TFE solutions or in the NOESY spectra of deamino-vasopressin in the presence of added molar ratio of neurophysin-II. Together with the transferred NOEs involving Cys 6 to Gly 9 , these results indicate that the three residue C-terminal tail of desmopressin may be involved in binding to neurophysin-II.
Three-dimensional Structure of Desmopressin Bound to Bovine Neurophysin-II-The bound structure of desmopressin to neurophysin-II has been generated using PEPFLEX-II (12), which is a computer program for the generation of structure(s) of flexible peptides, based on transferred NOE NMR data. On the right of Fig. 4 , we show 21 structures of desmopressin bound to neurophysin-II derived from 1 H-NMR transferred NOE data; on the left, we show the averaged bound structure derived from these structures. There are two fused ␤-turns in the structure that are located between residues Phe 3 and Gly 
Asn
5 at the iϩ1 and iϩ2 positions; the other is a type-II ␤-turn with residues Pro 7 and Arg 8 at positions iϩ1 and iϩ2, respectively. Two hydrogen bonds were found in the bound structure. One is between the amide proton of residue Phe 3 to the carbonyl oxygen atom of residue 6, and the other is between the amide proton of residue 6 to the carboxyl oxygen of residue 9. The bound structure of desmopressin is similar to one of the minor conformations of the peptide observed in aqueous solution (12) .
The most striking feature of the bound structure is the change in the conformation of the side chains of residues Tyr 2 , Phe 3 , Gln 4 , and Arg 8 that occurs upon binding to neurophysin-II. This suggests that the major interactions between desmopressin and neurophysin-II involve these side chains. Binding causes the positive charge on the side chain of Arg 8 to be in close proximity of the side chains of Tyr 2 or Phe 3 and the disulfide-bonded loop (see the left structure of Fig. 4) , suggesting that the C-terminal three-residue tail of desmopressin participates in the binding interactions. This is different from structure-function studies of vasopressin and other analogs, which indicate that the three-residue tail of these peptides is not involved in binding (1) . In the structures of the free peptide, the Tyr 2 side chain is one of the least well-refined side chain, indicating its high flexibility when the peptide is in either TFE or aqueous solutions (11, 12) . The flexibility of the Tyr 2 side chain of the peptide is significantly reduced in the bound structure, indicating a strong interaction between this side chain and neurophysin-II. However, the side chain of Phe 3 in the bound structure retains a certain flexibility, implying a looser interaction between Phe 3 and neurophysin-II. The strong interaction of the Tyr 2 side chain and the weak interaction of the Phe 3 side chain are analogous to interactions of vasopressin with neurophysin-II (1). Our previous results indicated that the disulfide bond is one of the most flexible part of desmopressin; its flexibility causes several different orientations of the three-residue tail in both TFE (11) and aqueous solution (12) . The flexibility of the disulfide bond remains in the bound structure of desmopressin. However, unlike the disulfide bond of the peptide in the free solution structures (12), this is not coupled to different orientations of the C-terminal three-residue tail (Fig. 4) .
DISCUSSION
In this study, a large excess of peptide over neurophysin-II was used for the transferred NOE experiments to minimize the NMR signals from neurophysin-II. Such an excess may lead to nonspecific binding (13) . However, our results indicate that the interaction between desmopressin and neurophysin-II is specific compared to the control experiment, which demonstrated that deamino-vasopressin does not bind to neurophysin-II under the same experimental conditions.
The current view of the binding mode between peptide hormones and neurophysin does not predict the binding of desmopressin to neurophysin (1), because it lacks the N-terminal ␣-amino group, which plays a crucial role in the binding of natural hormones vasopressin and oxytocin to neurophysin (1) . This group forms a strong salt bridge with the side chain carboxyl group of residue Glu 47 in neurophysin and hydrogen bonds to neurophysin-II backbone carbonyls of Glu (1), and a similar result is also seen in this paper for deamino-vasopressin. However, the acetimidation of this amino group does not change binding affinity or the binding-induced dimerization of the hormoneneurophysin complex (14) . This indicates that a longer and more bulky positive charge on the acetimidated group can also form a strong salt bridge. Both desmopressin and deaminovasopressin lack this N-terminal ␣-amino group. However, our NMR data indicate that although desmopressin binds to neurophysin-II, deamino-vasopressin does not. The only positive charge in desmopressin/deamino-vasopressin is that from the side chain of Arg 8 . Desmopressin has a D-arginine at position 8, and its three-residue tail forms a type II ␤-turn. This type II ␤-turn in desmopressin allows the three-residue tail to fold back to the disulfide-bonded moiety so that Arg 8 is close to Tyr 2 , potentially permitting the positive charge on the Arg 8 side chain to interact with neurophysin-II analogously to the ␣-amino group of the natural hormones. This interaction is not available to deamino-vasopressin because it has a L-arginine, and no ␤-turn has been found in its C-terminal three-residue tail. However, the distance between the Arg 8 side chain and neurophysin-II may not be as close as that of the ␣-amino group in vasopressin. Also, the side chain of Arg 8 is bulkier, even than the acetimidated amino group, and may necessitate conformational adjustments by the protein. These factors may influence the strength of the interaction between desmopressin and neurophysin-II and may, therefore, be responsible for a binding affinity difference between desmopressin and vasopressin.
Another important interaction between the natural hormone and neurophysin-II is that the aromatic side chain of Tyr 2 binds in a tight pocket with its hydroxyl group hydrogen bonded with neurophysin (1). The bound structure of desmopressin supports this interaction, although we cannot determine whether the hydroxyl group of the Tyr 2 side chain is hydrogen bonded with neurophysin-II. Although the side chain of Tyr 2 is the most flexible side chain of the peptide in its free solution structures (11, 12) , the binding to neurophysin-II significantly reduces its flexibility. The bound structure also indicates a certain mobility for the aromatic side chain of Phe 3 . This is also consistent with earlier studies of hormone-neurophysin complexes, which indicated that the side chain of Phe 3 binds to the protein principally via the ␤-methylene position (1). Furthermore, thermodynamic studies indicate hydrogenbonding between the hormone backbone of residue 2 and 3 to neurophysin (5, 15) , which was supported by 15 N NMR spectroscopy study (16) . In the crystal structure of the complex of Phe-Tyr-NH 2 with neurophysin-II, the terminal amide NH of the peptide is hydrogen-bonded to the protein (5). This is analogous to the amide proton of Phe 3 in our bound structure, which is directed to the inside of the 20-membered ring moiety. Similar observations were noted with the bound structure of oxytocin to neurophysin-I (6) .
The fact that the disulfide bond retains its flexibility in the bound structure of desmopressin suggests that it may not interact with neurophysin-II. This is interesting because earlier studies demonstrated that the disulfide bond of the peptide hormones binds to an apolar region of neurophysin (1) . This suggests that there are differences in the binding between desmopressin and vasopressin/oxytocin to neurophysin. The flexibility of the disulfide bond in the free solution structure causes different orientations of the three-residue tail, as we discussed previously (11, 12) ; however, the flexibility of the disulfide bond in the bound structure of desmopressin does not cause different orientations of the three-residue tail, as shown in Fig. 4 . This difference also supports the concept that the three-residue tail of desmopressin is involved in binding to neurophysin, because the conformation of the three-residue tail is fixed by the interaction between the side chain of Arg 8 and neurophysin-II.
Taken together, the results in the present study indicate both similarities and differences in the binding of desmopressin to neurophysin-II when compared with that of the natural hormones vasopressin and oxytocin. Fig. 5 compares the bound structure of desmopressin with the crystal structure (wet-form) of deamino-oxytocin (Protein Data Bank code 1XY1). Note that Rose et al. (7) reported recently that the conformation of the critical residues Cys 1 and Tyr 2 of this structure is similar to those of Cys 1 and Tyr 2 observed in the oxytocin-neurophysin complex. To mimic the bound form of oxytocin, the crystal structure of deamino-oxytocin was modified to include a NH 3 ϩ group in the N-terminal. ϩ in oxytocin, which was confirmed by the crystal structure of oxytocin bound to neurophysin (7) . In an analogous way, the positive charge of D-Arg 8 also orientates toward the Tyr 2 side chain in desmopressin. The orientation of the Tyr 2 side chain of the desmopressin bound structure is different from that of the structure of bound oxytocin in solution by Lippens et al. (6) . In the structure of bound oxytocin in solution, the Tyr 2 side chain points away from Cys toward the side chain of Tyr 2 in desmopressin. A similar result was also observed when the free crystal structure (wet-form) of deamino-oxytocin was compared with the crystal structure of the bound form of oxytocin (7) . The Ile 3 side chain in the bound form of oxytocin orientates toward the Tyr 2 side chain, as clearly shown in Fig. 5 of Ref. 7 .
The similarity between bound oxytocin and desmopressin suggests a possible common binding motif for all neurophyseal hormones, consisting of a positive charge, one apolar aromatic side chain, and a ␤-methylene group. The positive charge is from N-terminal NH 3 ϩ in vasopressin/oxytocin and from the positive side chain of D-Arg in desmopressin. The apolar aromatic side chain is from Tyr 2 , and the ␤-methylene is from Phe 3 . This common binding motif suggests that desmopressin may bind to neurophysin-II at its major hormone binding site. If desmopressin adopts an upside-down binding motif compared with that of oxytocin and vasopressin, the positive charge on D-Arg 8 can be directed toward the Tyr 2 side chain by the type-II ␤-turn in the C-terminal three-residue tail, thus forming the binding motif. Unlike oxytocin and vasopressin, the disulfide bond in desmopressin is away from this binding motif and is not involved in binding, therefore retaining its flexibility as shown in Fig. 4 . This proposed new binding mode of desmopressin may give new insights into the mechanism of ligand-protein recognition in this system and suggests an unexpected adaptability of the protein binding site to accommodate novel ligands.
